| 摘要 |
The present invention discloses a commercially viable asiaticoside composition having at least 99% purity that is derived from plant Centella asiatica and a manufacturing process thereof. The present invention further teaches a method and the models for oral administration of therapeutically effective amount of the asiaticoside models for oral administration of therapeutically effective amount of the asiaticoside composition for treatment of Inflammatory Bowel Diseases such as Ulcerative colitis, Crohn's disease and associated complications of inflammatory bowel diseases such as hemorrhoids, anal fissures, fistulas. The invention further provides a method and model for oral administration of therapeutically effective amount of the asiaticoside composition for treatment of Helicobacter Pylori. The invention further provides a method and the models for oral administration of therapeutically effective amount of the asiaticoside composition for prevention of colon cancer, gastric diseases and gastric carcinoma. |
